Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis.
Furrer
H
H
AIDS Unit, Medical Policlinic, University Hospital Bern, Switzerland.
Malinverni
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D019469:Indinavir / Q000009:adverse effects; D007249:Inflammation / Q000139:chemically induced* / Q000188:drug therapy; D019888:Nelfinavir / Q000009:adverse effects; D011241:Prednisone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy* / Q000209:etiology
D019380:Anti-HIV Agents; D000893:Anti-Inflammatory Agents; D000995:Antitubercular Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D011241:Prednisone